If you have dry age-related macular degeneration, your central vision may end up blurry, distorted or dim.

Full 12-month data from Ocugen’s phase 2 eye disease gene therapy show the therapy significantly reduces the size of lesions, though the treatment’s smaller effect compared to an earlier preliminary ...

Innovent Biologics’ eye disease prospect has matched Bayer and Regeneron’s Eylea in a phase 3 study, teeing up filings for ...

Discover the latest breakthroughs in the fight against dry, age-related macular degeneration. Learn about the first approved medicine and innovative treatments.

Optimal dose intended for Phase 3 demonstrates statistically significant reduction in lesion growth (31%) versus control at 12 months (p< ...

Add Yahoo as a preferred source to see more of our stories on Google. Iconic Fleetwood Mac frontwoman Stevie Nicks, 76, revealed she was diagnosed with wet macular degeneration in a recent interview ...

Metformin use in people with diabetes was linked to a significantly lower risk of developing intermediate age-related macular degeneration.

Conditions that resemble age-related macular degeneration (AMD) can differ considerably from AMD regarding prognosis, inheritance, monitoring and therapy. Differential diagnoses of AMD include other ...

Discover more about how a common diabetes drug can reduce the incidence of intermediate age-related macular degeneration.

Subretinal transplantation of retinal pigment epithelium derived from human embryonic stem cells (hESCs) appears to be a well-tolerated means of treating age-related macular degeneration and Stargardt ...